Curacao vs India: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Curacao
0.2%
in 2024
India
0.2%
in 2024
Curacao rank
99th
India rank
99th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Curacao
- India
How they compare
Curacao currently reports 0.2% against 0.2% in India, a difference of 0.0%.
Across all 10 years both countries report, India has been ahead every year.
Curacao ranks 99th and India ranks 99th of 247 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Curacao | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | India |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Curacao or India?
- Curacao, at 0.2% against 0.2% in India as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Curacao and India?
- 0.0%, with Curacao ahead.
- How many years of comparable data are there for Curacao and India?
- 10 years are reported by both, from 2015 to 2024.
- How do Curacao and India rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Curacao ranks 99th and India ranks 99th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.